These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9626902)

  • 1. The usefulness of Holter monitoring in selecting pharmacologic therapy for patients with sustained monomorphic ventricular tachycardia: studies in patients in whom no effective pharmacologic therapy could be determined by electrophysiologic study.
    Niwano S; Furushima H; Taneda K; Abe A; Ohira K; Aizawa Y
    Jpn Circ J; 1998 May; 62(5):347-52. PubMed ID: 9626902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.
    Reiffel JA; Reiter MJ; Freedman RA; Mann D; Huang SK; Hahn E; Hartz V; Mason J;
    Prog Cardiovasc Dis; 1996; 38(5):359-70. PubMed ID: 8604440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
    Niwano S; Yamaura M; Yoshizawa N; Moriguchi M; Kitano Y; Aizawa Y; Izumi T
    Jpn Circ J; 1999 Sep; 63(9):674-80. PubMed ID: 10496481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
    Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R
    Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
    Klein RC
    Eur Heart J; 1993 Nov; 14 Suppl H():78-84. PubMed ID: 8293756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
    Reiffel JA
    Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
    Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of Holter monitoring and electrophysiologic study in patients with coronary artery disease and sustained ventricular tachyarrhythmias.
    Swerdlow CD; Peterson J
    Am J Cardiol; 1985 Oct; 56(10):577-80. PubMed ID: 4050691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and EPS-guided therapy in 142 cases of sustained ventricular tachycardia.
    Ebe K; Aizawa Y; Shibata A
    Jpn Heart J; 1996 Jan; 37(1):73-84. PubMed ID: 8632627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases.
    Aiba T; Yamagata K; Shimizu W; Taguchi A; Satomi K; Noda T; Okamura H; Suyama K; Aihara N; Kamakura S; Kurita T
    Circ J; 2008 Jan; 72(1):88-93. PubMed ID: 18159106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of initial therapy in the Electrophysiological Study Versus ECG Monitoring trial (ESVEM).
    Omoigui NA; Marcus FI; Mason JW; Hahn EA; Hartz VL; Hlatky MA
    Circulation; 1995 Feb; 91(4):1070-6. PubMed ID: 7850943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of Holter ECG guided therapy for ventricular arrhythmias: the ESVEM trial.
    Lazzara R
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):473-7. PubMed ID: 7513876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients.
    Girgis I; Gualberti J; Langan L; Malek S; Mustaciuolo V; Costantino T; McGinn TG
    Chest; 1997 Sep; 112(3):646-53. PubMed ID: 9315796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of ω-3 polyunsaturated fatty acids on predictors of sudden cardiac death in patients with ischemic heart disease and ventricular rhythm disturbances].
    Gavva EM; Tsaregorodtsev DA; Mamedov IS; Sulimov VA
    Kardiologiia; 2012; 52(7):14-21. PubMed ID: 22839709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.